HDAC9 and hepatocellular carcinoma: As aberrant histone deacetylation causes silencing of tumor suppressors in many of the known cancers, and research has shown aberrant expression of HDAC in HCC [57, 58], thus HDACi offers a promising approach to treat HCC.